Fuzeon

Product manufactured by Genentech, Inc.

Application Nr Approved Date Route Status External Links
NDA021481 None None None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Fuzeon ® In Combination With Other Antiretroviral Agents Is Indicated For The Treatment Of Hiv-1 Infection In Treatment-Experienced Patients With Evidence Of Hiv-1 Replication Despite Ongoing Antiretroviral Therapy. Fuzeon Is An Hiv-1 Gp41 Fusion Inhibitor Indicated For Use In Combination With Other Antiretroviral Agents For The Treatment Of Hiv-1 Infection In Treatment-Experienced Patients With Hiv-1 Replication Despite Ongoing Antiretroviral Therapy. ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Enfuvirtide

Comments